Liver transplantation in autoimmune liver diseases

Best Practice and Research: Clinical Gastroenterology

Volumn 25, Issue 6, 2011, Pages 765-782

  Ilyas, Jawad A ^a,b   O'Mahony, Christine A ^a,b   Vierling, John M ^a,b  

^a ST LUKE S EPISCOPAL HOSPITAL   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Autoimmune hepatitis; Cholestatic liver diseases; Immunosuppression; Liver transplantation; Outcomes; Primary biliary cirrhosis; Primary sclerosing cholangitis; Recurrence

Indexed keywords

ANTINEOPLASTIC AGENT; AUTOANTIBODY; AZATHIOPRINE; BUDESONIDE; CYCLOSPORIN; PREDNISOLONE; PREDNISONE; RAPAMYCIN; STEROID; TACROLIMUS; URSODEOXYCHOLIC ACID;

ACUTE LIVER FAILURE; ALLOGRAFT; ARTICLE; AUTOIMMUNE HEPATITIS; BILE DUCT CARCINOMA; CHOLEDOCHOJEJUNOSTOMY; DIAGNOSTIC ACCURACY; DIFFERENTIAL DIAGNOSIS; DRUG MEGADOSE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; END STAGE LIVER DISEASE; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; GRAFT RECIPIENT; GRAFT SURVIVAL; HISTOPATHOLOGY; HUMAN; IMMUNOPATHOGENESIS; IMMUNOSUPPRESSIVE TREATMENT; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; MODEL FOR END STAGE LIVER DISEASE SCORE; PREDICTIVE VALUE; PRIMARY BILIARY CIRRHOSIS; PRIMARY SCLEROSING CHOLANGITIS; RECURRENCE RISK; RECURRENT DISEASE; RISK FACTOR; SCORING SYSTEM; SURVIVAL RATE; SURVIVAL TIME; TREATMENT FAILURE; TREATMENT INDICATION; TREATMENT OUTCOME; ULCERATIVE COLITIS;

CHOLANGITIS, SCLEROSING; COLITIS, ULCERATIVE; HEPATITIS, AUTOIMMUNE; HUMANS; IMMUNOSUPPRESSION; LIVER CIRRHOSIS, BILIARY; LIVER TRANSPLANTATION; RECURRENCE; TREATMENT OUTCOME;

EID: 82255191472     PISSN: 15216918     EISSN: 15321916     Source Type: Journal    
DOI: 10.1016/j.bpg.2011.09.008     Document Type: Article

References (113)

1. A. Ahmed, and E.B. Keeffe Current indications and contraindications for liver transplantation Clin Liver Dis 11 2 2007 May 227 247 (Pubitemid 46990959)
2. A.J. Czaja Corticosteroids or not in severe acute or fulminant autoimmune hepatitis: therapeutic brinksmanship and the point beyond salvation Liver Transpl 13 7 2007 Jul 953 955 (Pubitemid 47163184)
3. P. Ichai, J.C. Duclos-Vallee, C. Guettier, S.B. Hamida, T. Antonini, and V. Delvart Usefulness of corticosteroids for the treatment of severe and fulminant forms of autoimmune hepatitis Liver Transpl 13 7 2007 Jul 996 1003 (Pubitemid 47163192)
4. J.G. O'Grady Phenotypic expression of recurrent disease after liver transplantation Am J Transpl 10 5 2010 May 1149 1154
5. M.P. Manns, and M.J. Bahr Recurrent autoimmune hepatitis after liver transplantation-when non-self becomes self Hepatology 32 4 Pt 1 2000 Oct 868 870
6. L.E. Holz, G.W. McCaughan, V. Benseler, P. Bertolino, and D.G. Bowen Liver tolerance and the manipulation of immune outcomes Inflamm Allergy Drug Targets 7 1 2008 Mar 6 18 (Pubitemid 351663641)
7. V. Benseler, G.W. McCaughan, H.J. Schlitt, G.A. Bishop, D.G. Bowen, and P. Bertolino The liver: a special case in transplantation tolerance Semin Liver Dis 27 2 2007 May 194 213 (Pubitemid 46871664)
8. V. Balan, K. Ruppert, A.J. Demetris, T. Ledneva, R.J. Duquesnoy, and K.M. Detre Long-term outcome of human leukocyte antigen mismatching in liver transplantation: results of the National Institute of Diabetes and Digestive and Kidney Diseases Liver Transplantation Database Hepatology 48 3 2008 Sep 878 888
9. M.P. Manns, A.J. Czaja, and J.D. Gorham Diagnosis and management of autoimmune hepatitis Hepatology 51 6 2010 2193 2213
10. S. Ferri, M.S. Longhi, M.C. de, C. Lalanne, P. Muratori, and A. Granito A multifaceted imbalance of T cells with regulatory function characterizes type 1 autoimmune hepatitis Hepatology 52 3 2010 Sep 999 1007
11. A.J. Czaja Autoimmune hepatitis. Part A: pathogenesis Expert Rev Gastroenterol Hepatol 1 1 2007 Oct 113 128
12. E.C. Seaberg, S.H. Belle, K.C. Beringer, J.L. Schivins, and K.M. Detre Liver transplantation in the United States from 1987-1998: updated results from the Pitt-UNOS liver transplant Registry Clin Transpl 1998 17 37
13. B.H. Ferraz-Neto, R. Hidalgo, T. Thome, V.A. Melo Jr., A. Lobue, and M.P. Zurstrassen Analysis of Model for End-Stage Liver Disease (MELD) score in a liver transplantation waiting list Transpl Proc 39 8 2007 Oct 2511 2513 (Pubitemid 47588353)
14. R.B. Freeman Jr., R.G. Gish, A. Harper, G.L. Davis, J. Vierling, and L. Lieblein Model for end-stage liver disease (MELD) exception guidelines: results and recommendations from the MELD Exception Study Group and Conference (MESSAGE) for the approval of patients who need liver transplantation with diseases not considered by the standard MELD formula Liver Transpl 12 12 Suppl. 3 2006 Dec S128 S136 (Pubitemid 44911794)
15. A.J. Czaja Difficult treatment decisions in autoimmune hepatitis World J Gastroenterol 16 8 2010 Feb 28 934 947
16. A.J. Montano-Loza, H.A. Carpenter, and A.J. Czaja Features associated with treatment failure in type 1 autoimmune hepatitis and predictive value of the model of end-stage liver disease Hepatology 46 4 2007 Oct 1138 1145 (Pubitemid 350144778)
17. A.J. Czaja, M.D. Strettell, L.J. Thomson, P.J. Santrach, S.B. Moore, and P.T. Donaldson Associations between alleles of the major histocompatibility complex and type 1 autoimmune hepatitis Hepatology 25 2 1997 Feb 317 323 (Pubitemid 27069049)
18. P. Tan, P. Marotta, C. Ghent, and P. Adams Early treatment response predicts the need for liver transplantation in autoimmune hepatitis Liver Int 25 4 2005 Aug 728 733 (Pubitemid 41038653)
19. R. Ferrari, G. Pappas, D. Agostinelli, P. Muratori, L. Muratori, and M. Lenzi Type 1 autoimmune hepatitis: patterns of clinical presentation and differential diagnosis of the 'acute' type QJM 97 7 2004 Jul 407 412 (Pubitemid 38967414)
20. S. Verma, A. Maheshwari, and P. Thuluvath Liver failure as initial presentation of autoimmune hepatitis: clinical characteristics, predictors of response to steroid therapy, and outcomes Hepatology 49 4 2009 Apr 1396 1397
21. S. Verma In type 1 autoimmune hepatitis (AIH), should remission be redefined as normalization of transaminases? J Hepatol 44 4 2006 Apr 819 820
22. F. Alvarez, P.A. Berg, F.B. Bianchi, L. Bianchi, A.K. Burroughs, and E.L. Cancado International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis J Hepatol 31 5 1999 Nov 929 938 (Pubitemid 29514229)
23. E.M. Hennes, M. Zeniya, A.J. Czaja, A. Pares, G.N. Dalekos, and E.L. Krawitt Simplified criteria for the diagnosis of autoimmune hepatitis Hepatology 48 1 2008 Jul 169 176 (Pubitemid 351975541)
24. J.R. Potts, and S. Verma Optimizing management in autoimmune hepatitis with liver failure at initial presentation World J Gastroenterol 17 16 2011 Apr 28 2070 2075
25. H. Hofer, C. Oesterreicher, F. Wrba, P. Ferenci, and E. Penner Centrilobular necrosis in autoimmune hepatitis: a histological feature associated with acute clinical presentation J Clin Pathol 59 3 2006 Mar 246 249 (Pubitemid 43344883)
26. W.R. Kessler, O.W. Cummings, G. Eckert, N. Chalasani, L. Lumeng, and P.Y. Kwo Fulminant hepatic failure as the initial presentation of acute autoimmune hepatitis Clin Gastroenterol Hepatol 2 7 2004 Jul 625 631 (Pubitemid 38834047)
27. R.T. Stravitz, J.H. Lefkowitch, R.J. Fontana, M.E. Gershwin, P.S. Leung, and R.K. Sterling Autoimmune acute liver failure: proposed clinical and histological criteria Hepatology 53 2 2011 Feb 517 526
28. Y. Miyake, Y. Iwasaki, R. Terada, T. Onishi, R. Okamoto, and N. Sakai Clinical characteristics of fulminant-type autoimmune hepatitis: an analysis of eleven cases Aliment Pharmacol Ther 23 9 2006 May 1 1347 1353
29. A.G. Villamil, P. Casciato, and M. Eduardo Fulminant autoimmune hepatitis type 1:Clinical presentation, outcome and prognostic factors(Abstract 480) AJT 5 Suppl. 11 2011 278
30. W. Gelson, M. Hoare, M.F. Dawwas, S. Vowler, P. Gibbs, and G. Alexander The pattern of late mortality in liver transplant recipients in the United Kingdom Transplantation 91 11 2011 Jun 15 1240 1244
31. J.C. Duclos-Vallee, F. Yilmaz, C. Johanet, A.M. Roque-Afonso, M. Gigou, and C. Trichet Could post-liver transplantation course be helpful for the diagnosis of so called cryptogenic cirrhosis? Clin Transpl 19 5 2005 Oct 591 599 (Pubitemid 41341689)
32. A.J. Demetris, O. Adeyi, C.O. Bellamy, A. Clouston, F. Charlotte, and A. Czaja Liver biopsy interpretation for causes of late liver allograft dysfunction Hepatology 44 2 2006 Aug 489 501 (Pubitemid 44214890)
33. V. Ratziu, D. Samuel, M. Sebagh, O. Farges, F. Saliba, and P. Ichai Long-term follow-up after liver transplantation for autoimmune hepatitis: evidence of recurrence of primary disease J Hepatol 30 1 1999 Jan 131 141 (Pubitemid 29023662)
34. T.C. Schreuder, S.G. Hubscher, and J. Neuberger Autoimmune liver diseases and recurrence after orthotopic liver transplantation: what have we learned so far? Transpl Int 22 2 2009 Feb 144 152
35. J.C. Duclos-Vallee, M. Sebagh, K. Rifai, C. Johanet, E. Ballot, and C. Guettier A 10 year follow up study of patients transplanted for autoimmune hepatitis: histological recurrence precedes clinical and biochemical recurrence Gut 52 6 2003 Jun 893 897 (Pubitemid 36613499)
36. J.C. Duclos-Vallee, and M. Sebagh Recurrence of autoimmune disease, primary sclerosing cholangitis, primary biliary cirrhosis, and autoimmune hepatitis after liver transplantation Liver Transpl 15 Suppl. 2 2009 Nov S25 S34
37. G. Ayata, F.D. Gordon, W.D. Lewis, E. Pomfret, J.J. Pomposelli, and R.L. Jenkins Liver transplantation for autoimmune hepatitis: a long-term pathologic study Hepatology 32 2 2000 Aug 185 192 (Pubitemid 30614649)
38. D.J. Reich, I. Fiel, J.V. Guarrera, S. Emre, S.R. Guy, and M.E. Schwartz Liver transplantation for autoimmune hepatitis Hepatology 32 4 Pt 1 2000 Oct 693 700
39. M. Gautam, R. Cheruvattath, and V. Balan Recurrence of autoimmune liver disease after liver transplantation: a systematic review Liver Transpl 12 12 2006 Dec 1813 1824 (Pubitemid 44911808)
40. M.S. Longhi, Y. Ma, G. Mieli-Vergani, and D. Vergani Aetiopathogenesis of autoimmune hepatitis J Autoimmun 34 1 2010 Feb 7 14
41. A.J. Montano-Loza, A.L. Mason, M. Ma, R.J. Bastiampillai, V.G. Bain, and P. Tandon Risk factors for recurrence of autoimmune hepatitis after liver transplantation Liver Transpl 15 10 2009 Oct 1254 1261
42. P. Milkiewicz, S.G. Hubscher, G. Skiba, M. Hathaway, and E. Elias Recurrence of autoimmune hepatitis after liver transplantation Transplantation 68 2 1999 Jul 27 253 256 (Pubitemid 29360286)
43. J. Neuberger, B. Portmann, R. Calne, and R. Williams Recurrence of autoimmune chronic active hepatitis following orthotopic liver grafting Transplantation 37 4 1984 Apr 363 365 (Pubitemid 14105426)
44. H.L. Wright, C.F. Bou-Abboud, T. Hassanein, G.D. Block, A.J. Demetris, and T.E. Starzl Disease recurrence and rejection following liver transplantation for autoimmune chronic active liver disease Transplantation 53 1 1992 Jan 136 139
45. H. Khalaf, W. Mourad, Y. El-Sheikh, A. Abdo, A. Helmy, and Y. Medhat Liver transplantation for autoimmune hepatitis: a single-center experience Transpl Proc 39 4 2007 May 1166 1170 (Pubitemid 46764831)
46. M. Hurtova, J.C. Duclos-Vallee, C. Johanet, J.F. Emile, A.M. Roque-Afonso, and C. Feray Successful tacrolimus therapy for a severe recurrence of type 1 autoimmune hepatitis in a liver graft recipient Liver Transpl 7 6 2001 Jun 556 558 (Pubitemid 32547275)
47. N. Kerkar, C. Dugan, C. Rumbo, R.A. Morotti, G. Gondolesi, and B.L. Shneider Rapamycin successfully treats post-transplant autoimmune hepatitis Am J Transpl 5 5 2005 May 1085 1089 (Pubitemid 40571258)
48. J. Campsen, M.A. Zimmerman, J.F. Trotter, M. Wachs, T. Bak, and T. Steinberg Liver transplantation for autoimmune hepatitis and the success of aggressive corticosteroid withdrawal Liver Transpl 14 9 2008 Sep 1281 1286
49. T.E. Trouillot, R. Shrestha, I. Kam, M. Wachs, and G.T. Everson Successful withdrawal of prednisone after adult liver transplantation for autoimmune hepatitis Liver Transpl Surg 5 5 1999 Sep 375 380 (Pubitemid 29437014)
50. J. Neuberger, and D. Jothimani Long-term immunosuppression for prevention of nonviral disease recurrence Transpl Proc 37 4 2005 May 1671 1674 (Pubitemid 40790791)
51. M.P. Manns, M. Woynarowski, W. Kreisel, Y. Lurie, C. Rust, and E. Zuckerman Budesonide induces remission more effectively than prednisone in a controlled trial of patients with autoimmune hepatitis Gastroenterology 139 4 2010 Oct 1198 1206
52. D. Tripathi, and J. Neuberger Autoimmune hepatitis and liver transplantation: indications, results, and management of recurrent disease Semin Liver Dis 29 3 2009 Aug 286 296
53. I.A. Rowe, K. Webb, B.K. Gunson, N. Mehta, S. Haque, and J. Neuberger The impact of disease recurrence on graft survival following liver transplantation: a single centre experience Transpl Int 21 5 2008 May 459 465 (Pubitemid 351490169)
54. M. Guido, and P. Burra De novo autoimmune hepatitis after liver transplantation Semin Liver Dis 31 1 2011 Feb 71 81
55. N. Kerkar, N. Hadzic, E.T. Davies, B. Portmann, P.T. Donaldson, and M. Rela De-novo autoimmune hepatitis after liver transplantation Lancet 351 9100 1998 Feb 7 409 413 (Pubitemid 28064165)
56. M.A. Heneghan, B.C. Portmann, S.M. Norris, R. Williams, P. Muiesan, and M. Rela Graft dysfunction mimicking autoimmune hepatitis following liver transplantation in adults Hepatology 34 3 2001 Sep 464 470 (Pubitemid 32791325)
57. P. Gupta, J. Hart, J.M. Millis, D. Cronin, and L. Brady De novo hepatitis with autoimmune antibodies and atypical histology: a rare cause of late graft dysfunction after pediatric liver transplantation Transplantation 71 5 2001 Mar 15 664 668 (Pubitemid 32268071)
58. N.E. Gibelli, U. Tannuri, E.S. Mello, E.R. Cancado, M.M. Santos, and A.A. Ayoub Successful treatment of de novo autoimmune hepatitis and cirrhosis after pediatric liver transplantation Pediatr Transpl 10 3 2006 May 371 376
59. C. Selmi, C.L. Bowlus, M.E. Gershwin, and R.L. Coppel Primary biliary cirrhosis Lancet 377 9777 2011 May 7 1600 1609
60. J. Lee, A. Belanger, J.T. Doucette, C. Stanca, S. Friedman, and N. Bach Transplantation trends in primary biliary cirrhosis Clin Gastroenterol Hepatol 5 11 2007 Nov 1313 1315 (Pubitemid 350019058)
61. SRTR database 2011 http://optn.transplant.hrsa.gov/ar2009/901a-li.pdf 8.05.11
62. J. Neuberger Liver transplantation for primary biliary cirrhosis Autoimmun Rev 2 1 2003 Jan 1 7 (Pubitemid 37443864)
63. S.C. Abraham, P.S. Kamath, B. Eghtesad, A.J. Demetris, and A.M. Krasinskas Liver transplantation in precirrhotic biliary tract disease: portal hypertension is frequently associated with nodular regenerative hyperplasia and obliterative portal venopathy Am J Surg Pathol 30 11 2006 Nov 1454 1461 (Pubitemid 44655482)
64. W.R. Kim, R.H. Wiesner, T.M. Therneau, J.J. Poterucha, M.K. Porayko, and R.W. Evans Optimal timing of liver transplantation for primary biliary cirrhosis Hepatology 28 1 1998 Jul 33 38 (Pubitemid 28299982)
65. C.E. Garcia, R.F. Garcia, B. Gunson, E. Christensen, J. Neuberger, and P. McMaster Analysis of marginal donor parameters in liver transplantation for primary biliary cirrhosis Exp Clin Transpl 2 1 2004 Jun 183 188
66. R. Kashyap, S. Safadjou, R. Chen, P. Mantry, R. Sharma, and V. Patil Living donor and deceased donor liver transplantation for autoimmune and cholestatic liver diseases-an analysis of the UNOS database J Gastrointest Surg 14 9 2010 Sep 1362 1369
67. M.G. Silveira, J.A. Talwalkar, K.D. Lindor, and R.H. Wiesner Recurrent primary biliary cirrhosis after liver transplantation Am J Transpl 10 4 2010 Apr 720 726
68. D.A. Jacob, U.P. Neumann, M. Bahra, J. Klupp, G. Puhl, and R. Neuhaus Long-term follow-up after recurrence of primary biliary cirrhosis after liver transplantation in 100 patients Clin Transpl 20 2 2006 Mar 211 220
69. R. Klein, J.R. Huizenga, C.H. Gips, and P.A. Berg Antimitochondrial antibody profiles in patients with primary biliary cirrhosis before orthotopic liver transplantation and titres of antimitochondrial antibody-subtypes after transplantation J Hepatol 20 2 1994 Feb 181 189 (Pubitemid 24086831)
70. B. Luettig, K.H. Boeker, W. Schoessler, H. Will, S. Loges, and E. Schmidt The antinuclear autoantibodies Sp100 and gp210 persist after orthotopic liver transplantation in patients with primary biliary cirrhosis J Hepatol 28 5 1998 May 824 828 (Pubitemid 28223487)
71. P. Charatcharoenwitthaya, S. Pimentel, J.A. Talwalkar, F.T. Enders, K.D. Lindor, and R.A. Krom Long-term survival and impact of ursodeoxycholic acid treatment for recurrent primary biliary cirrhosis after liver transplantation Liver Transpl 13 9 2007 Sep 1236 1245 (Pubitemid 47457050)
72. E.Q. Sanchez, M.F. Levy, R.M. Goldstein, C.G. Fasola, G.W. Tillery, and G.J. Netto The changing clinical presentation of recurrent primary biliary cirrhosis after liver transplantation Transplantation 76 11 2003 Dec 15 1583 1588 (Pubitemid 37549831)
73. P.B. Sylvestre, K.P. Batts, L.J. Burgart, J.J. Poterucha, and R.H. Wiesner Recurrence of primary biliary cirrhosis after liver transplantation: histologic estimate of incidence and natural history Liver Transpl 9 10 2003 Oct 1086 1093 (Pubitemid 37304465)
74. U. Khettry, N. Anand, P.N. Faul, W.D. Lewis, E.A. Pomfret, and J. Pomposelli Liver transplantation for primary biliary cirrhosis: a long-term pathologic study Liver Transpl 9 1 2003 Jan 87 96 (Pubitemid 36104920)
75. A. Lleo, C.L. Bowlus, G.X. Yang, P. Invernizzi, M. Podda, and W.J. Van De Biliary apotopes and anti-mitochondrial antibodies activate innate immune responses in primary biliary cirrhosis Hepatology 52 3 2010 Sep 987 998
76. H. Robertson, J.A. Kirby, W.W. Yip, D.E. Jones, and A.D. Burt Biliary epithelial-mesenchymal transition in posttransplantation recurrence of primary biliary cirrhosis Hepatology 45 4 2007 Apr 977 981 (Pubitemid 46631566)
77. D.A. Jacob, U.P. Neumann, M. Bahra, J.M. Langrehr, and P. Neuhaus Liver transplantation for primary biliary cirrhosis: influence of primary immunosuppression on survival Transpl Proc 37 4 2005 May 1691 1692 (Pubitemid 40790797)
78. J. Neuberger, B. Gunson, S. Hubscher, and P. Nightingale Immunosuppression affects the rate of recurrent primary biliary cirrhosis after liver transplantation Liver Transpl 10 4 2004 Apr 488 491 (Pubitemid 38443587)
79. A.J. Montano-Loza, S. Wasilenko, J. Bintner, and A.L. Mason Cyclosporine A protects against primary biliary cirrhosis recurrence after liver transplantation Am J Transpl 10 4 2010 Apr 852 858
80. P. Manousou, V. Arvaniti, E. Tsochatzis, G. Isgro, K. Jones, and G. Shirling Primary biliary cirrhosis after liver transplantation: influence of immunosuppression and human leukocyte antigen locus disparity Liver Transpl 16 1 2010 Jan 64 73
81. J. Levitsky, J. Hart, and S.M. Cohen The effect of immunosuppressive regimens on the recurrence of primary biliary cirrhosis after liver transplantation Liver Transpl 9 7 2003 Jul 733 736 (Pubitemid 36874462)
82. D.A. Jacob, E. Haase, F. Klein, J. Pratschke, U.P. Neumann, and P. Neuhaus Donor influence on outcome in patients undergoing liver transplant for primary biliary cirrhosis Exp Clin Transpl 8 2 2010 Jun 104 110
83. S.C. Abraham, J.J. Poterucha, C.B. Rosen, A.J. Demetris, and A.M. Krasinskas Histologic abnormalities are common in protocol liver allograft biopsies from patients with normal liver function tests Am J Surg Pathol 32 7 2008 Jul 965 973
84. J.R. Maggs, and R.W. Chapman An update on primary sclerosing cholangitis Curr Opin Gastroenterol 24 3 2008 May 377 383 (Pubitemid 351535898)
85. R. Chapman, J. Fevery, A. Kalloo, D.M. Nagorney, K.M. Boberg, and B. Shneider Diagnosis and management of primary sclerosing cholangitis Hepatology 51 2 2010 Feb 660 678
86. C.A. O'Mahony, and J.M. Vierling Etiopathogenesis of primary sclerosing cholangitis Semin Liver Dis 26 1 2006 Feb 3 21 (Pubitemid 43320723)
87. B. Terjung, J. Sohne, B. Lechtenberg, J. Gottwein, M. Muennich, and V. Herzog p-ANCAs in autoimmune liver disorders recognise human beta-tubulin isotype 5 and cross-react with microbial protein FtsZ Gut 59 6 2010 Jun 808 816
88. R.H. Wiesner Liver transplantation for primary sclerosing cholangitis: timing, outcome, impact of inflammatory bowel disease and recurrence of disease Best Pract Res Clin Gastroenterol 15 4 2001 Aug 667 680 (Pubitemid 32747018)
89. C. Landaverde, V. Ng, A. Sato, J. Tabibian, F. Durazo, and R. Busuttil De-novo cholangiocarcinoma in native common bile duct remnant following OLT for primary sclerosing cholangitis Ann Hepatol 8 4 2009 Oct 379 383
90. K.L. Mathis, E.J. Dozois, D.W. Larson, R.R. Cima, J.M. Sarmiento, and B.G. Wolff Ileal pouch-anal anastomosis and liver transplantation for ulcerative colitis complicated by primary sclerosing cholangitis Br J Surg 95 7 2008 Jul 882 886
91. L. Zhang, J.T. Lewis, S.C. Abraham, T.C. Smyrk, S. Leung, and S.T. Chari IgG4+ plasma cell infiltrates in liver explants with primary sclerosing cholangitis Am J Surg Pathol 34 1 2010 Jan 88 94
92. B. Frider, A. Bruno, M. Zylberman, A. Oria, and M. Amante Autoimmune cholangitis associated to IgG4 related sclerosing disease Acta Gastroenterol Latinoam 41 1 2011 Mar 55 59
93. W.R. Kim, J.J. Poterucha, R.H. Wiesner, N.F. LaRusso, K.D. Lindor, and J. Petz The relative role of the Child-Pugh classification and the Mayo natural history model in the assessment of survival in patients with primary sclerosing cholangitis Hepatology 29 6 1999 Jun 1643 1648 (Pubitemid 29247033)
94. C.Y. Ponsioen, S.M. Vrouenraets, W. Prawirodirdjo, R. Rajaram, E.A. Rauws, and C.J. Mulder Natural history of primary sclerosing cholangitis and prognostic value of cholangiography in a Dutch population Gut 51 4 2002 Oct 562 566
95. G. Rudolph, D. Gotthardt, P. Kloters-Plachky, H. Kulaksiz, D. Rost, and A. Stiehl Influence of dominant bile duct stenoses and biliary infections on outcome in primary sclerosing cholangitis J Hepatol 51 1 2009 Jul 149 155
96. R. Kashyap, P. Mantry, R. Sharma, M.K. Maloo, S. Safadjou, and Y. Qi Comparative analysis of outcomes in living and deceased donor liver transplants for primary sclerosing cholangitis J Gastrointest Surg 13 8 2009 Aug 1480 1486
97. J.A. Goss, C.R. Shackleton, D.G. Farmer, W.S. Arnaout, P. Seu, and J.S. Markowitz Orthotopic liver transplantation for primary sclerosing cholangitis. A 12-year single center experience Ann Surg 225 5 1997 May 472 481
98. J. Fevery, and C. Verslype An update on cholangiocarcinoma associated with primary sclerosing cholangitis Curr Opin Gastroenterol 26 3 2010 May 236 245
99. G.J. Gores, D.M. Nagorney, and C.B. Rosen Cholangiocarcinoma: is transplantation an option? for whom? J Hepatol 47 4 2007 Oct 455 459 (Pubitemid 47331754)
100. J.M. Ali, L. Bonomo, and R. Brais Outcomes and diagnostic challenges posed by incidental cholangiocarcinoma after liver transplantation Transplantation 91 12 2011 Jun 27 1392 1397
101. P. Ghali, P.J. Marotta, E.M. Yoshida, V.G. Bain, D. Marleau, and K. Peltekian Liver transplantation for incidental cholangiocarcinoma: analysis of the Canadian experience Liver Transpl 11 11 2005 Nov 1412 1416 (Pubitemid 43071591)
102. N.S. Becker, J.A. Rodriguez, N.R. Barshes, C.A. O'Mahony, J.A. Goss, and T.A. Aloia Outcomes analysis for 280 patients with cholangiocarcinoma treated with liver transplantation over an 18-year period J Gastrointest Surg 12 1 2008 Jan 117 122
103. J.C. Hong, H. Petrowsky, F.M. Kaldas, D.G. Farmer, F.A. Durazo, and R.S. Finn Predictive index for tumor recurrence after liver transplantation for locally advanced intrahepatic and hilar cholangiocarcinoma J Am Coll Surg 212 4 2011 Apr 514 520
104. L.H. Katz, O. Benjaminov, A. Belinki, A. Geler, M. Braun, and M. Knizhnik Magnetic resonance cholangiopancreatography for the accurate diagnosis of biliary complications after liver transplantation: comparison with endoscopic retrograde cholangiography and percutaneous transhepatic cholangiography - long-term follow-up Clin Transpl 24 5 2010 Sep E163 E169
105. I.W. Graziadei, R.H. Wiesner, P.J. Marotta, M.K. Porayko, J.E. Hay, and M.R. Charlton Long-term results of patients undergoing liver transplantation for primary sclerosing cholangitis Hepatology 30 5 1999 Nov 1121 1127 (Pubitemid 29510847)
106. J. Campsen, M.A. Zimmerman, J.F. Trotter, M. Wachs, T. Bak, and T. Steinberg Clinically recurrent primary sclerosing cholangitis following liver transplantation: a time course Liver Transpl 14 2 2008 Feb 181 185 (Pubitemid 351267274)
107. E. Alabraba, P. Nightingale, B. Gunson, S. Hubscher, S. Olliff, and D. Mirza A re-evaluation of the risk factors for the recurrence of primary sclerosing cholangitis in liver allografts Liver Transpl 15 3 2009 Mar 330 340
108. A. Vera, S. Moledina, B. Gunson, S. Hubscher, D. Mirza, and S. Olliff Risk factors for recurrence of primary sclerosing cholangitis of liver allograft Lancet 360 9349 2002 Dec 14 1943 1944 (Pubitemid 35472138)
109. J. Alexander, J.D. Lord, M.M. Yeh, C. Cuevas, R. Bakthavatsalam, and K.V. Kowdley Risk factors for recurrence of primary sclerosing cholangitis after liver transplantation Liver Transpl 14 2 2008 Feb 245 251 (Pubitemid 351267284)
110. I.W. Graziadei Live donor liver transplantation for primary sclerosing cholangitis: is disease recurrence increased? Curr Opin Gastroenterol 27 3 2011 May 301 305
111. A. Maheshwari, H.Y. Yoo, and P.J. Thuluvath Long-term outcome of liver transplantation in patients with PSC: a comparative analysis with PBC Am J Gastroenterol 99 3 2004 Mar 538 542 (Pubitemid 38524137)
112. I.W. Graziadei Recurrence of primary sclerosing cholangitis after liver transplantation Liver Transpl 8 7 2002 Jul 575 581 (Pubitemid 34752702)
113. R.C. Verdonk, G. Dijkstra, E.B. Haagsma, V.K. Shostrom, A.P. Van den Berg, and J.H. Kleibeuker Inflammatory bowel disease after liver transplantation: risk factors for recurrence and de novo disease Am J Transpl 6 6 2006 Jun 1422 1429 (Pubitemid 44030325)